These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32597829)

  • 21. Wnt5a/Ror2 pathway contributes to the regulation of cholesterol homeostasis and inflammatory response in atherosclerosis.
    Zhang CJ; Zhu N; Liu Z; Shi Z; Long J; Zu XY; Tang ZW; Hu ZY; Liao DF; Qin L
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158547. PubMed ID: 31678514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells.
    Woodsome TP; Polzin A; Kitazawa K; Eto M; Kitazawa T
    J Cell Sci; 2006 May; 119(Pt 9):1769-80. PubMed ID: 16608882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haplodeficiency of Klotho Gene Causes Arterial Stiffening via Upregulation of Scleraxis Expression and Induction of Autophagy.
    Chen K; Zhou X; Sun Z
    Hypertension; 2015 Nov; 66(5):1006-13. PubMed ID: 26324504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
    Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
    Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling.
    Ren XS; Tong Y; Ling L; Chen D; Sun HJ; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Physiol Biochem; 2017; 44(6):2269-2280. PubMed ID: 29262411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smooth muscle-specific TMEM16A expression protects against angiotensin II-induced cerebrovascular remodeling via suppressing extracellular matrix deposition.
    Zeng XL; Sun L; Zheng HQ; Wang GL; Du YH; Lv XF; Ma MM; Guan YY
    J Mol Cell Cardiol; 2019 Sep; 134():131-143. PubMed ID: 31301303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation.
    Qi F; Ogawa K; Tokinaga Y; Uematsu N; Minonishi T; Hatano Y
    Anesth Analg; 2009 Aug; 109(2):412-7. PubMed ID: 19608811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.
    Tabet F; Schiffrin EL; Callera GE; He Y; Yao G; Ostman A; Kappert K; Tonks NK; Touyz RM
    Circ Res; 2008 Jul; 103(2):149-58. PubMed ID: 18566342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho.
    Chang JR; Guo J; Wang Y; Hou YL; Lu WW; Zhang JS; Yu YR; Xu MJ; Liu XY; Wang XJ; Guan YF; Zhu Y; Du J; Tang CS; Qi YF
    Kidney Int; 2016 Mar; 89(3):586-600. PubMed ID: 26880455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
    Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T
    Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conditional knockout of collecting duct bradykinin B2 receptors exacerbates angiotensin II-induced hypertension during high salt intake.
    Kopkan L; Husková Z; Jíchová Š; Červenková L; Červenka L; Saifudeen Z; El-Dahr SS
    Clin Exp Hypertens; 2016; 38(1):1-9. PubMed ID: 26151827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure-associated polymorphism controls ARHGAP42 expression via serum response factor DNA binding.
    Bai X; Mangum KD; Dee RA; Stouffer GA; Lee CR; Oni-Orisan A; Patterson C; Schisler JC; Viera AJ; Taylor JM; Mack CP
    J Clin Invest; 2017 Feb; 127(2):670-680. PubMed ID: 28112683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition.
    Nakano-Kurimoto R; Ikeda K; Uraoka M; Nakagawa Y; Yutaka K; Koide M; Takahashi T; Matoba S; Yamada H; Okigaki M; Matsubara H
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1673-84. PubMed ID: 19749165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.
    Marchesi C; Rehman A; Rautureau Y; Kasal DA; Briet M; Leibowitz A; Simeone SM; Ebrahimian T; Neves MF; Offermanns S; Gonzalez FJ; Paradis P; Schiffrin EL
    Cardiovasc Res; 2013 Mar; 97(3):562-70. PubMed ID: 23250918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FNDC5 Attenuates Oxidative Stress and NLRP3 Inflammasome Activation in Vascular Smooth Muscle Cells via Activating the AMPK-SIRT1 Signal Pathway.
    Zhou B; Qiu Y; Wu N; Chen AD; Zhou H; Chen Q; Kang YM; Li YH; Zhu GQ
    Oxid Med Cell Longev; 2020; 2020():6384803. PubMed ID: 32509148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL6 suppression provides renal protection independent of blood pressure in a murine model of salt-sensitive hypertension.
    Manhiani MM; Quigley JE; Socha MJ; Motamed K; Imig JD
    Kidney Blood Press Res; 2007; 30(4):195-202. PubMed ID: 17575466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
    Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
    Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation.
    Zhou X; Chen K; Lei H; Sun Z
    J Am Soc Nephrol; 2015 Jan; 26(1):121-32. PubMed ID: 24904083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural vascular changes in hypertension: role of angiotensin II, dietary sodium supplementation, blood pressure, and time.
    Simon G; Illyes G; Csiky B
    Hypertension; 1998 Oct; 32(4):654-60. PubMed ID: 9774359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathway.
    Bihl JC; Zhang C; Zhao Y; Xiao X; Ma X; Chen Y; Chen S; Zhao B; Chen Y
    Vascul Pharmacol; 2015 Oct; 73():115-123. PubMed ID: 26264508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.